BTIG Reiterates Buy Rating on Sophia Genetics SA (SOPH)

May 6, 2026 5:58 AM

BTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on Sophia Genetics SA (NASDAQ: SOPH).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found